Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
-3.26M
-
Total reported value, excl. options
-
$101M
-
Value change
-
-$43.5M
-
Put/Call ratio
-
0.91
-
Number of buys
-
45
-
Number of sells
-
-41
-
Price
-
$6.22
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q1 2016
104 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2016.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 54.8M outstanding shares and own 29.62% of the company stock.
Largest 10 shareholders include RHO CAPITAL PARTNERS INC (3.07M shares), FMR LLC (1.59M shares), Sectoral Asset Management Inc (1.21M shares), CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD (997K shares), BlackRock Fund Advisors (870K shares), Opaleye Management Inc. (855K shares), VANGUARD GROUP INC (687K shares), JENNISON ASSOCIATES LLC (661K shares), FRANKLIN RESOURCES INC (611K shares), and JPMORGAN CHASE & CO (513K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.